-
Real-World Analysis of Treatment Patterns and Disease Exacerbations Among Patients Initiating Therapy for Myasthenia Gravis
Sep 9, 2025, 16:22 PM -
Baseline Characteristics and Treatment Persistence in UK Patients With Moderate-to-Severe UC Following 12-Week Mirikizumab Induction: Real-World Data From IBD BioResource
Sep 9, 2025, 16:22 PM -
Reevaluating Cost-Effectiveness: A Holistic Framework for Assessing Disease-Modifying Treatments in Type 1 Diabetes
Sep 9, 2025, 16:22 PM -
Economic Evaluation of Cefiderocol for the Treatment of Confirmed MBL-Producing Pathogens in Italy
Sep 9, 2025, 16:22 PM -
Guideline-Driven Off-Label Oncology Use: The Role of Clinical Evidence and Reimbursement Dynamics in the EU4+UK, Switzerland, and Canada
Sep 9, 2025, 16:22 PM -
Operational and Economic Impact of CLL Treatment Regimens: Insights From a Multidisciplinary Study in Portugal
Sep 9, 2025, 16:22 PM -
A Proof of Concept Study to Build a Japanese-Based Electronic Medical Record Data Model Suited for Real-World Research
Sep 9, 2025, 16:22 PM -
Constructing a Dynamic Budget Impact Model: An AI Pretraining Approach for a New Parkinson's Disease Drug
Sep 9, 2025, 16:22 PM -
Patients’ Advocacy Groups in Italy: An Updated Perspective on Activities and Future Directions
Sep 9, 2025, 16:22 PM -
Real-World Adherence to Nonhormonal Therapies for Menopause-Related Vasomotor Symptoms: A Targeted Literature Review
Sep 9, 2025, 16:22 PM -
Improving Patient Flow and Multidisciplinary Coordination in Urothelial Carcinoma: Insights From Bulgarian Oncologists
Sep 9, 2025, 16:22 PM -
Estimating Health Utility Decrements Associated With Chronic Disease Outcomes Using MEPS
Sep 9, 2025, 16:22 PM -
A Health Economic Evaluation of Daylight: A Digital Treatment for Anxiety in NHS South Yorkshire
Sep 9, 2025, 16:22 PM -
Assessment of the Inclusion and Importance of Carer Quality of Life in Global Health Technology Appraisals
Sep 9, 2025, 16:22 PM -
Are Glucagon-Like Peptide-1 Receptor Agonists Prescribed for Weight Loss Slipping Through the Net of Japan’s Strict Guidelines? An Analysis of Health Insurance Claims Data
Sep 9, 2025, 16:22 PM -
The Interim Acceptance and Ultraorphan Pathways in Scotland: An Update
Sep 9, 2025, 16:22 PM -
What Is the Impact of Patient Voice on NICE Recommendations for Drugs Assessed in 2024?
Sep 9, 2025, 16:22 PM -
Comparison of Time-Driven Activity-Based Costs Incurred by Patients and Caregivers Related to Intravitreal Injections for Retinal Vein Occlusion
Sep 9, 2025, 16:22 PM -
Reducing Healthcare Costs and Addressing Health Equity Through Improved Treatment Adherence and Reduced Exacerbation Risk in Chronic Obstructive Pulmonary Disease: Real-World Evidence From a Danish Nationwide Cohort Study
Sep 9, 2025, 16:22 PM -
Adherence to Anti-VEGF Treatment of Patients With Age-Related Macular Degeneration of Exudative Type (nAMD) and Diabetic Macular Edema (DME) in Greece: Evidence From an Expert Panel
Sep 9, 2025, 16:22 PM
